Guo J - Search Results

1

Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.

Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, Huang L. Yu Z, et al. Among authors: guo j. J Nanobiotechnology. 2022 Jan 4;20(1):9. doi: 10.1186/s12951-021-01205-8. J Nanobiotechnology. 2022. PMID: 34983554 Free PMC article.

2

The Application of Pre-clinical Animal Models to Optimise Nanoparticulate Drug Delivery for Hepatocellular Carcinoma.

Zhang Z, Song L, Guo J. Zhang Z, et al. Among authors: guo j. Pharm Nanotechnol. 2018;6(4):221-231. doi: 10.2174/2211738506666181001121533. Pharm Nanotechnol. 2018. PMID: 30277174 Review.

3

Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma.

Yu Z, Guo J, Hu M, Gao Y, Huang L. Yu Z, et al. Among authors: guo j. ACS Nano. 2020 Apr 28;14(4):4816-4828. doi: 10.1021/acsnano.0c00708. Epub 2020 Mar 23. ACS Nano. 2020. PMID: 32188241

4

Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.

Liu Y, Guo J, Huang L. Liu Y, et al. Among authors: guo j. Theranostics. 2020 Feb 10;10(7):3099-3117. doi: 10.7150/thno.42998. eCollection 2020. Theranostics. 2020. PMID: 32194857 Free PMC article. Review.

5

Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis.

Guo J, Yu Z, Das M, Huang L. Guo J, et al. ACS Nano. 2020 Apr 28;14(4):5075-5089. doi: 10.1021/acsnano.0c01676. Epub 2020 Apr 16. ACS Nano. 2020. PMID: 32283007

6

Membrane-core nanoparticles for cancer nanomedicine.

Guo J, Huang L. Guo J, et al. Adv Drug Deliv Rev. 2020;156:23-39. doi: 10.1016/j.addr.2020.05.005. Epub 2020 May 22. Adv Drug Deliv Rev. 2020. PMID: 32450105 Free PMC article. Review.

7

Tackling TAMs for Cancer Immunotherapy: It's Nano Time.

Yang Y, Guo J, Huang L. Yang Y, et al. Among authors: guo j. Trends Pharmacol Sci. 2020 Oct;41(10):701-714. doi: 10.1016/j.tips.2020.08.003. Trends Pharmacol Sci. 2020. PMID: 32946772 Free PMC article. Review.

8

Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy.

Sun D, Zhang J, Wang L, Yu Z, O'Driscoll CM, Guo J. Sun D, et al. Among authors: guo j. Drug Discov Today. 2021 Mar;26(3):651-662. doi: 10.1016/j.drudis.2020.11.029. Epub 2020 Dec 2. Drug Discov Today. 2021. PMID: 33278602 Review. No abstract available.

9

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.

Guo J, Yu Z, Sun D, Zou Y, Liu Y, Huang L. Guo J, et al. Mol Cancer. 2021 Jan 6;20(1):10. doi: 10.1186/s12943-020-01297-0. Mol Cancer. 2021. PMID: 33407548 Free PMC article.

10

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

Zou Y, Xiao F, Song L, Sun B, Sun D, Chu D, Wang L, Han S, Yu Z, O'Driscoll CM, Guo J. Zou Y, et al. Among authors: guo j. Int J Pharm. 2021 Sep 5;606:120888. doi: 10.1016/j.ijpharm.2021.120888. Epub 2021 Jul 14. Int J Pharm. 2021. PMID: 34271152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,045 results

Search Page

Filters